Sublingual Semaglutide (generic Ozempic®) now available! Get Started
Dashboard
Formulas

Semaglutide 0.5 mg/mL Sublingual Suspension

Our Semaglutide 0.5 mg/mL Sublingual Suspension is a meticulously crafted liquid formulation, contained within pre-dosed oral syringes for precise dosing. This innovative suspension is specifically designed for sublingual administration, allowing for the medication to be easily dropped under the tongue.

The formulation utilizes SubMagna™ SL HMW base, an advanced anhydrous vehicle that is self-emulsifying and permeation-enhancing, tailored to deliver drugs, including those with high molecular weights. The sublingual route also bypasses gastrointestinal factors that can affect bioavailability, offering a more direct pathway into the bloodstream.

Patients often include semaglutide in their regimens for managing type 2 diabetes, obesity, and weight.

This formulation is NOT the injectable version, and we do not guarantee efficacy. Results may vary.

Want a different strength?
Click the Text Us button below.
To prescribe, you must be a verified prescriber.
To prescribe, you must be in a state where we hold an active out-of-state pharmacy license.
Starting at
$180 per Month
Must be E-Prescribed
Get Started
Generate LeafletShow Leaflet
This medication requires a prescription from your doctor
Are you a prescriber? Sign Up
Trusted by 60,357 patients to date.
A group of faces of our past satisfied patients.
A svg symbol of a mortar and pestle with ingredients going in.
Custom made in our compounding labs.
Sliders that show the customization of ingredients.
Personalized treatment for better results.
User with a gear showing the personalization of the formulation.
All strengths and ingredients are tailored to your needs.
This medication is not available at retail pharmacies. It is compounded, and may be more effective at treating you or your patient.
Oral Syringe
65dcebeea92455f9aa66c8fb
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Loading icon rotating.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Dosing Calculator

Get general dosing information for a patient by using this calculator.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Loading icon rotating.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Formula Information

A small arrow pointing down

Our Semaglutide 0.5 mg/mL Sublingual Suspension is a meticulously crafted liquid formulation, specifically designed for sublingual administration. This advanced delivery system is encapsulated in pre-dosed oral syringes, which allows for precise dosing and ease of use. The formulation is particularly suitable for patients who require smaller doses or for those who may face challenges swallowing traditional solid dosage forms, such as tablets or capsules. The sublingual route is advantageous as it bypasses the gastrointestinal tract, potentially reducing the impact of gastric variables on the drug's bioavailability.

The cutting-edge SubMagna™ SL HMW base used in this formulation is engineered to deliver a broad spectrum of drugs, including those with high molecular weights. Upon application under the tongue, SubMagna™ SL HMW interacts with saliva to form an emulsion, which enhances the solubility and dispersibility of the active pharmaceutical ingredient (API). This is particularly beneficial for Semaglutide, a peptide drug with a relatively large molecular structure. The base's permeation-enhancing and mucoadhesive properties are designed to facilitate the transport of molecules into the mucosal tissues, extending the duration of contact and potentially improving absorption.

As an anhydrous, self-emulsifying vehicle, SubMagna™ SL HMW offers the added advantage of potentially extended beyond-use-dates (BUDs), which can be particularly important for maintaining the stability and efficacy of the medication over time. This is especially relevant for Semaglutide, which is used in the management of type 2 diabetes and as an adjunct to diet and exercise to improve glycemic control in adults. By optimizing the delivery and absorption of Semaglutide, our sublingual suspension formulation may enhance the therapeutic outcomes for patients with type 2 diabetes.

For patients and prescribers considering this innovative Semaglutide 0.5 mg/mL Sublingual Suspension, it represents a promising alternative to conventional administration routes, offering the potential for improved pharmacokinetics and patient compliance. If you have any questions or require further information about this formulation, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of expert compounding pharmacists is dedicated to providing comprehensive support and guidance to ensure the best possible care for our patients.

Drug Interactions

A small arrow pointing down

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used in the management of type 2 diabetes mellitus to improve glycemic control in conjunction with diet and exercise. It functions by enhancing insulin secretion, suppressing glucagon secretion, and slowing gastric emptying. When considering drug interactions for semaglutide, it is important to note that the sublingual route of administration may alter the interaction profile compared to the more commonly used subcutaneous route.

One significant interaction to be aware of is with insulin or other medications that lower blood glucose, such as sulfonylureas. The concurrent use of semaglutide with these agents can increase the risk of hypoglycemia. Patients should be monitored closely for signs of low blood sugar, and dosages of concomitant antidiabetic medications may need to be adjusted accordingly.

Drugs that affect gastrointestinal motility, such as prokinetic agents or anticholinergic drugs, may interact with semaglutide. Since semaglutide slows gastric emptying, the use of these drugs concurrently could either enhance or diminish the effect of semaglutide on gastric emptying, potentially affecting its efficacy and the absorption of other orally administered medications.

Additionally, medications that have a narrow therapeutic index and are highly dependent on plasma concentration for efficacy or safety, such as warfarin, may require closer monitoring when initiating or discontinuing semaglutide therapy. Changes in gastric emptying induced by semaglutide could affect the absorption and, consequently, the plasma levels of these medications.

It is also important to consider the impact of the SubMagna SL HMW base on drug interactions. The permeation-enhancing and mucoadhesive properties of the base may alter the absorption kinetics of semaglutide or co-administered drugs. While this can be beneficial for the absorption of semaglutide, it may also affect the sublingual absorption of other medications. Patients should be advised to separate the administration of other sublingual medications from semaglutide to prevent potential interactions.

Patients should be counseled to inform their healthcare providers of all medications they are taking, including prescription drugs, over-the-counter medications, and herbal supplements. This is crucial for identifying potential drug interactions and adjusting therapy as needed to ensure safety and efficacy.

For prescribers, it is recommended to review the patient's medication profile for potential interactions with semaglutide and to monitor the patient's response to therapy after initiating or modifying treatment with semaglutide. Adjustments to therapy should be made based on clinical judgment and patient response.

If you have any questions or require further information regarding the drug interactions associated with semaglutide 0.5 mg/mL Sublingual Suspension or its use with the SubMagna SL HMW base, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide support and guidance to ensure the safe use of this medication.

How Does it Work

A small arrow pointing down

The semaglutide 0.5 mg/mL sublingual suspension is a specialized medication designed for the treatment of type 2 diabetes. This innovative formulation utilizes SubMagna™ SL HMW base, which is specifically engineered to deliver drugs sublingually, directly under the tongue. The sublingual route is particularly beneficial for medications like semaglutide, which have a high molecular weight and may have reduced bioavailability when taken orally due to degradation in the gastrointestinal tract.

How does it work? When the semaglutide sublingual suspension is administered under the tongue using the pre-dosed oral syringe, the anhydrous SubMagna base interacts with saliva to form an emulsion. This process enhances the solubility and dispersibility of the active pharmaceutical ingredient (API), semaglutide, in the oral mucosa. The base's permeation-enhancing properties facilitate the transport of semaglutide into the mucosal tissues, while its mucoadhesive characteristics prolong the contact time between the medication and the absorption site. This extended contact time can lead to increased absorption of the drug into the bloodstream.

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, which mimics the action of the naturally occurring hormone GLP-1. It works by stimulating insulin secretion and reducing glucagon secretion in a glucose-dependent manner, thereby lowering blood sugar levels. Additionally, semaglutide slows gastric emptying and reduces appetite, which can contribute to weight loss in patients with type 2 diabetes.

The sublingual suspension formulation is particularly advantageous for patients who may have difficulty swallowing pills or for those who require precise dosing that can be easily adjusted. The anhydrous nature of the SubMagna base also contributes to potentially longer beyond-use-dates (BUDs), which can improve the shelf life of the medication.

For patients and prescribers considering this formulation, it is important to note that the sublingual administration of semaglutide bypasses the gastrointestinal system, which can lead to a more consistent absorption profile and may reduce gastrointestinal side effects commonly associated with GLP-1 receptor agonists. This can be particularly beneficial for patients who have experienced gastrointestinal intolerance with other diabetes medications.

If you have any questions about the semaglutide 0.5 mg/mL sublingual suspension or its administration, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide you with the information and support you need.

Other Uses

A small arrow pointing down

While the primary indication for semaglutide 0.5 mg/mL Sublingual Suspension is the management of type 2 diabetes mellitus, due to its mechanism of action as a glucagon-like peptide-1 (GLP-1) receptor agonist, there may be potential for off-label uses that prescribers could consider. For instance, semaglutide has been studied for its effects on weight management in individuals with obesity or overweight, as it can reduce appetite and food intake. The sublingual delivery of semaglutide in our specially formulated SubMagna™ SL HMW base may offer an alternative for patients who have difficulty with injections or for whom oral formulations are not suitable due to gastrointestinal side effects or reduced bioavailability.

Furthermore, the unique properties of the SubMagna™ SL HMW base, which is designed to enhance the permeation of high molecular weight substances, could potentially be leveraged for other peptide or protein-based therapies that require improved mucosal absorption. The sublingual route bypasses the hepatic first-pass metabolism, which could be beneficial for drugs that are extensively metabolized in the liver. This could expand the therapeutic applications of the sublingual suspension to include other areas such as endocrinology, where peptide hormones play a crucial role.

It is important to note that any off-label use of semaglutide or other medications should be based on sound clinical evidence and undertaken with the full knowledge and consent of the patient. The sublingual suspension formulation may also offer advantages in terms of stability and shelf-life, as the anhydrous nature of SubMagna™ SL HMW can potentially extend beyond-use-dates, reducing waste and improving the convenience for patients who require long-term medication management.

As compounding pharmacists at Bayview Pharmacy, we are committed to providing comprehensive information and support to both patients and prescribers considering the use of semaglutide 0.5 mg/mL Sublingual Suspension or exploring its potential in other therapeutic areas. We encourage healthcare professionals to discuss with us the suitability of this formulation for their patients' specific needs, and we are available to answer any questions regarding the preparation, administration, and storage of this medication. Our goal is to ensure safe treatment outcomes for all our patients.

Frequently Asked Questions

A small arrow pointing down

What is Semaglutide 0.5 mg/mL Sublingual Suspension?

Semaglutide 0.5 mg/mL Sublingual Suspension is a liquid medication formulated for sublingual administration. It is dispensed in pre-dosed oral syringes for precise dosing and is designed to be absorbed under the tongue, bypassing the gastrointestinal tract for potentially improved bioavailability.

How do I take Semaglutide Sublingual Suspension?

To take Semaglutide Sublingual Suspension, use the oral syringe provided to dispense the prescribed amount under your tongue. Hold the suspension sublingually for the recommended amount of time before swallowing to ensure proper absorption.

What is SubMagna™ SL HMW base?

SubMagna™ SL HMW is an advanced sublingual suspension vehicle that is anhydrous, self-emulsifying, and permeation-enhancing. It is specifically designed to deliver drugs of varying molecular weights, including high molecular weight substances, efficiently through the mucosal tissues under the tongue.

Why is the sublingual route used for Semaglutide Suspension?

The sublingual route is used for Semaglutide Suspension to potentially increase the drug's bioavailability by avoiding degradation in the gastrointestinal tract and first-pass metabolism in the liver. This route also allows for rapid absorption through the mucosal tissues under the tongue.

Can children use Semaglutide Sublingual Suspension?

Semaglutide Sublingual Suspension may be suitable for pediatric patients, especially those who have difficulty swallowing tablets or capsules. However, it is essential to consult a healthcare provider for appropriate dosing and to determine if this medication is safe for a child's specific condition.

What are the benefits of SubMagna™ SL HMW base in this formulation?

The SubMagna™ SL HMW base enhances the solubility and dispersibility of the active pharmaceutical ingredient (API) when it comes into contact with saliva. Its mucoadhesive properties prolong contact time with mucosal tissues, potentially allowing for greater absorption of the medication.

How should I store the Semaglutide Sublingual Suspension?

Store the Semaglutide Sublingual Suspension according to the instructions provided by the pharmacy. Typically, it should be kept in a cool, dry place away from direct sunlight and out of reach of children. Do not freeze the suspension.

What should I do if I miss a dose of Semaglutide Sublingual Suspension?

If you miss a dose of Semaglutide Sublingual Suspension, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and resume your regular dosing schedule. Do not double the dose to catch up.

Are there any side effects associated with Semaglutide Sublingual Suspension?

As with any medication, Semaglutide Sublingual Suspension may cause side effects. Common side effects can include nausea, headache, and dizziness. If you experience any severe or persistent side effects, contact your healthcare provider immediately.

Can I eat or drink immediately after taking Semaglutide Sublingual Suspension?

It is generally recommended to wait a few minutes after taking Semaglutide Sublingual Suspension before eating or drinking. This allows the medication to be fully absorbed sublingually. Follow any specific instructions provided by your healthcare provider or pharmacist.

Related Formulas

Related Products
Formulas and/or material listed are not to be interpreted as a promise, guarantee or claim of therapeutic efficacy or safety. The information contained herein is not intended to replace or substitute for conventional medical care, or encourage its abandonment. Every patient is unique, and formulas should be adjusted to meet their individual needs.

No compounded medications are reviewed by the FDA for safety or efficacy.
NEW PRESCRIPTION ORDER FORM
1
Circle for steps.
Patient Information
2
Circle for steps.
Prescriber and Prescription Information
3
Circle for steps.
Fax order form to Bayview Pharmacy at 401-284-4506.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.